Uncategorized

Research and development (R&D) sits at the heart of the pharmaceutical industry. It’s the process that turns bold scientific ideas into treatments that can change, or even save, lives. Unlike tech or consumer products, where new releases can hit the market in months, pharma innovation is a long game. Developing a single new drug can … Read more

Australia’s mining sector is facing a defining decade. Declining ore grades, mounting decarbonisation pressure, and the global race for critical minerals are pushing companies to innovate at pace. Yet pilot plants, electrification trials, and novel processing methods demand upfront capital—often before traditional funding cycles align. The numbers tell the story. Mining R&D expenditure in Australia … Read more

In the tech world, building in isolation used to be the badge of honour. But today, the fastest-growing companies know better — scaling from scrappy startup to market leader rarely happens alone. Whether you’re launching a new product, entering an emerging market, or trying to outpace the competition, the right tech partnership can be the … Read more

Something strange is happening in Australia’s business world. At a time when technology is advancing faster than ever, when AI is reshaping entire industries, breakthrough medical treatments are extending lives, and clean energy is revolutionising how we power our world, Australian companies are actually investing less in research and development. It doesn’t make sense, does … Read more

Australia’s mining sector is at a turning point. Faced with rising demand for critical minerals, tighter environmental regulations, and growing scrutiny from investors and communities, the industry is under pressure to operate cleaner, safer, and more efficiently. Innovation in Mining is stepping up to meet the challenge. From autonomous vehicles and AI-driven exploration to real-time … Read more

Australia’s research and development landscape is about to change in a big way. The Australian Government has kicked off an independent strategic examination of research and development to overhaul how the country supports innovation. Final recommendations are due by 31 December 2025. For founders, CFOs and emerging sectors like AI and biotech, what happens next … Read more

Here’s an interesting contradiction: the Reserve Bank of Australia has cut interest rates twice in 2025, bringing the cash rate down to 3.60%. That should mean more investment, right? Not quite. According to the RBA’s August 2025 Statement, business investment is actually expected to flat-line through 2025–26. As a result, most companies are hitting pause … Read more

Pharmaceutical innovations play a vital role in transforming healthcare, advancing medical research, and boosting economic growth. From groundbreaking drug discoveries to advancements in biotechnology, Australia’s pharmaceutical sector is evolving rapidly, driven by cutting-edge research, technological advancements, and government support. This article dives into the key trends, challenges, and opportunities shaping pharmaceutical innovations in Australia and … Read more

The R&D Tax Incentive (R&DTI) is one of Australia’s most generous innovation funding mechanisms. For any startup company focused on building something new, whether a product or service, it can be the difference between stretching your runway or stalling out too soon. But while the rebate is designed to support growth, startup mistakes around timing, … Read more

Funding is one of the most critical decisions a founder or CFO will make. The type of capital you raise affects not just your balance sheet, but your ownership, control, and long-term valuation. Yet, in the rush to extend runways or fuel growth, many businesses jump into a raise without fully considering the trade-offs. Understanding … Read more